0001231919-26-000307.txt : 20260403 0001231919-26-000307.hdr.sgml : 20260403 20260403142803 ACCESSION NUMBER: 0001231919-26-000307 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260403 DATE AS OF CHANGE: 20260403 EFFECTIVENESS DATE: 20260403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tempest Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-579044 FILM NUMBER: 26837697 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-798-8589 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Millendo Therapeutics, Inc. DATE OF NAME CHANGE: 20181207 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 D 1 primary_doc.xml X0708 D LIVE 0001544227 Tempest Therapeutics, Inc. 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA CALIFORNIA 94005 415-798-8589 DELAWARE Millendo Therapeutics, Inc. OvaScience, Inc. Corporation true Matthew Angel c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Director Nicholas Maestas c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Michael Raab c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Christine Pellizzari c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Ronit Simantov c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Stephen Brady c/o Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Biotechnology No Revenues 06b false 2026-03-20 false true true true false 0 1999539 1999539 0 false 3 105000 0 0 false Tempest Therapeutics, Inc. /s/ Matthew Angel Matthew Angel President and CEO 2026-04-03